AR-C86398KA

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAR-C86398KA
Drug Alias NameAR-C86398KA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor modulators
TargetsPurinergic receptor
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca R&D Charnwood
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca R&D Charnwood
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A